PART B: VALORISATION PLAN
SECTION I: ESTIMATION OF COSTS
1 |
Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result. |
… in terms of IPR protection | |
M.E.G. has been already protected by a patent.
|
|
…in terms of product development | |
In terms of product development, Innov@ctors needs a product developer for 2 months (about 4.000 €) for the required development, deployment, testing and engineering.
|
|
…in terms of mass production | |
At the moment, the mass production costs are not predictable.
|
|
… in terms of marketing | |
It can be estimate a marketing cost of about 30.000 € per year (promotion, fairs, conventions, ..).
|
2 |
Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs |
|||||
|
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
|
Fixed costs |
30.000 |
30.000 |
35.000 |
|
|
|
Personnel |
70.000 |
70.000 |
100.000 |
|
|
|
Other running costs |
50.000 |
70.000 |
200.000 |
|
|
|
Marketing costs |
30.000 |
30.000 |
30.000 |
|
|
|
TOTAL EXPECTED COSTS |
180.000 |
200.000 |
365.000 |
|
|
|
Price per Unit |
25.000 |
25.000 |
25.000 |
|
|
|
Type of Unit |
M.E.G. |
|||||
Number of Units |
5 |
10 |
25 |
|
|
|
TOTAL Expected Revenues |
125.000 |
250.000 |
625.000 |
|
|
|
CASH FLOW REQUIRED (REVENUES-COSTS) |
-55.000 |
50.000 |
260.000 |
|
|
|
TOTAL CAPITAL required for five years |
0 |
|||||
SECTION 2: QUALITATIVE FACTORS
4 |
Dimension of identified target groups |
The system is directed to public administration bodies like Municipalities and to companies. In Italy, there are more than 8.000 municipalities and more than 4 millions of companies (0,5% of them are medium or large companies). Municipalities: we could estimate to reach 4% of the Italian Municipalities (320) Companies: we could estimate to reach 10% of the Italian Medium and Large Companies (2.000)
|
6 |
Evaluation of financial Risks for R&D result |
The project has not particular financial risks.
|
SECTION 3: IDENTIFICATION OF FINANCING SOURCES
After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)
Define relevance of the product with the following potential funding sources and comment |
|
1. … FP7 2. …FP8 3. … 4. … 5. … |
2 National Funding |
|
1. … LR 4/2005 (Friuli Venezia Giulia regional law for the development of innovative projects whose objective is the company growth) 2. …LR 26/2005 (Friuli Venezia Giulia regional law on innovation) 3. …LR 47/78 (Friuli Venezia Giulia regional law for the realization of research, development and innvation projects) 4. … … |
3 Private funding |
|
1. … Business angels and venture capitalists. 2. …Private capital 3. … 4. … … |
4 Other |
|
|
SECTION 3: FINAL EVALUATION
It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)… |
In order to better define the market and the economic and financial feasibility, Innov@ctors should invest time in a market survey and in the project business model definition.
|
Decision of evaluation (Please tick as appropriate)
|
The R&D has a high potential of exploitation |
þ |
The R&D result needs minor revisions |
|
The R&D result needs moderate revisions |
|
The R&D result needs major revisions |
|
The R&D result has no potential of exploitation |